Believe me, I am hanging in there - been in this too long not to hang in. And I know that small biotech companies are subject to wild fluctuations. However, when a stock drops from $8.00 to $3.50 in the span of a few months and the news concerning the company is positive, in general, it causes a person to scratch their head and become concerned.
Even if the 2nd quarter numbers are good, the reporting on the results usually accentuates the portion of the earnings report that did not "meet expectations". It seems that the stock price is unusually susceptible to "minor" disappointing news driving the price down. Again, head scratching and a point for concern...
News 
Market Data 
Discover 
